Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy

Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration

(2022) Sho Kawaguchi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer

(2021) Keiichiro Kumamoto et al.   Frontiers in Oncology

High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer

(2021) Toshiki Anami et al.   Medical Molecular Morphology

Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy

(2020) Ioana Plesca et al.   Frontiers in Immunology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

(2019) Jérôme Galon et al.   NATURE REVIEWS DRUG DISCOVERY

CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis

(2018) Touko Asano et al.   CANCER SCIENCE

High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer

(2018) Hiroto Takeya et al.   PATHOLOGY INTERNATIONAL

Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma

(2016) Koji Ohnishi et al.   CANCER SCIENCE

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma

(2015) Y. Saito et al.   Cancer Immunology Research

Preclinical Evidence for the Pharmacological Actions of Naringin: A Review

(2014) Saurabh Bharti et al.   PLANTA MEDICA

CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma

(2013) Koji Ohnishi et al.   CANCER SCIENCE

Oncology Meets Immunology: The Cancer-Immunity Cycle

(2013) Daniel S. Chen et al.   IMMUNITY

Lymph Node Macrophages

(2012) Elizabeth E. Gray et al.   Journal of Innate Immunity

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens

(2010) Kenichi Asano et al.   IMMUNITY